Priority driven research
Overview
Cancer Australia administers a dedicated cancer research budget of $4 million per annum.
The Priority-driven Collaborative Cancer Research Scheme is a funding program to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.
Cancer Australia has established the scheme to partner with other organisations that fund cancer research to:
- better coordinate funding of priority-driven cancer research,
- foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
- foster consumer participation in cancer research, from design to implementation.
The National Health and Medical Research Council (NHMRC) facilitates registration and initial assessment of applications, and will endorse grants funded through this scheme.
2009 Round of the Priority-driven Collaborative Cancer Research Scheme: Announcement of Research Priorities
Cancer Australia and its funding partners are pleased to announce the research priorities for the 2009 Round of the Priority-driven Collaborative Cancer Research Scheme (revised 17 November 2008).
Funding will be available for research that addresses the priorities of one or more of the following funding partners:
- Cancer Australia
- Cancer Australia: National Centre For Gynaecological Cancers
- beyondblue: the national depression initiative
- Cancer Council Australia
- CanTeen, Starlight Children’s Foundation Australia and beyondblue
- Cure Cancer Australia Foundation
- Leukaemia Foundation
- Meat & Livestock Australia
- National Breast Cancer Foundation
- Prostate Cancer Foundation of Australia
- Radiation Oncology Section of Department of Health and Ageing
Research priorities for the 2009 round of the Priority-driven Collaborative Cancer Research Scheme have been announced in early October to encourage discussion, collaboration, and planning between researchers prior to the call for applications.
Applications will open in early December 2008.
Successful applicants for 2007 Round
Cancer Australia, the National Breast Cancer Foundation, the Prostate Cancer Foundation of Australia, and Diagnostics and Technology Branch of the Australia Government Department of Health and Ageing are pleased to announce the successful applicants in the 2007 Round of the Priority-driven Collaborative Cancer Research Scheme.
National Health and Medical Research Council and Cancer Australia – partners in cancer research: a joint statement by the National Health and Medical Research Council and Cancer Australia.
The Priority-driven Collaborative Cancer Research Scheme is an innovative research funding scheme which brings together government and other funders of cancer research to collaboratively fund cancer research in Australia. This research scheme is managed by Cancer Australia together with the NHMRC. The NHMRC and Cancer Australia have prepared a joint statement highlighting how research supported through the Priority-driven Collaborative Cancer Research Scheme complements cancer research activities funded by the NHMRC.
National Health and Medical Research Council and Cancer Australia – partners in cancer research: a joint statement by the National Health and Medical Research Council and Cancer Australia
Applications for 2008 grants (now closed)
Cancer Australia and our 2008 funding partners – beyondblue, Cure Cancer Australia Foundation, The Cancer Council Australia, and the National Breast Cancer Foundation – invited applications for Priority-driven Collaborative Cancer Research Grants to commence in 2008. The call for applications to the Priority-driven Collaborative Cancer Research Scheme for 2008 closed on March 14 2008.
Researchers working in Australia were eligible to apply. Project grants will be offered to support research for a period of up to three years. Funding up to $600 000 (GST exclusive) over three years were available with a maximum, in any one year, of $200 000 (GST exclusive). However, all project grant applications ranging from 1 to 3 years within a budget ranging from $10 000 to $200 000 per annum will be considered.
Project grants of one year duration for up to $75 000 (GST exclusive) will also be offered by the Cure Cancer Australia Foundation, to support post-doctoral researchers with less than 5 years post-doctoral experience undertaking research into malignant disease.
Contact: Dr Paul Jackson at Cancer Australia